Summary: Insulin detemir is a long-acting, neutral, and soluble insulin analogue with a lower within-subject variability of fasting plasma glucose levels than isophane insulin human (NPH insulin ...

a DB = double-blind, DM = diabetes mellitus, HbA 1c = glycosylated hemoglobin, MC = multicenter, NPH = isophane insulin human, NR = not recorded, OL = open-label, PG = parallel-group, R = randomized.

Use of the long-acting insulin analogs glargine and detemir does not reduce the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus (T1DM), compared with the ...

Cipla to introduce Afrezza, an inhaled insulin for diabetes, offering convenience but not advised for lung-related concerns.

By type of insulin, the long-acting insulin analogs segment accounted for the highest revenue-grossing segment in the global ...

The 1930s saw the introduction of medium and long acting insulins, following the discovery, by Hagedorn, that addition of protamine to insulin preparations prolonged insulin action by slowing ...

Novo will drop its U.S. list price for its Fiasp by 75% and for Tresiba by 72%, the Danish company said in a release. The new ...

Levemir is a long-acting insulin that’s used to control high blood sugar levels in adults and children with type 1 and type 2 diabetes. There are alternative insulins that could replace Levemir ...

An insulin pump is a wearable device that some people with diabetes use to get insulin, instead of getting it from an injection. The small pump runs on batteries and delivers short-acting insulin ...